You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 264 Correlation of virus-specific CD8+ T cells to clinical response following treatment with Pexa-Vec and Cemiplimab in patients with advanced renal cell carcinoma

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
264 Correlation of virus-specific CD8+ T cells to clinical response following treatment with Pexa-Vec and Cemiplimab in patients with advanced renal cell carcinoma

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 20201927048
Dec 202010602
Jan 20214803
Feb 20211602
Mar 20215006
Apr 20212804
May 20211005
Jun 20210011
Jul 2021009
Aug 2021005
Sep 2021002
Oct 202122020
Nov 202112017
Dec 20211801
Jan 20223207
Feb 20221604
Mar 20221400
Apr 20223003
May 20222000
Jun 20223803
Jul 20222600
Aug 20222404
Sep 20221801
Oct 20222403
Nov 20222403
Dec 20221200
Jan 20233401
Feb 20236202
Mar 20231602
Apr 2023801
May 20232000
Jun 20231000
Jul 20231803
Aug 2023801
Sep 20231000
Oct 20231802
Nov 20231601
Dec 20233601
Jan 20243000
Feb 2024800
Mar 20241100
Apr 20241600
May 20241800
Jun 20241600
Jul 20245200
Aug 20243807
Sep 20242001
Oct 20241606
Nov 20241802
Dec 20242408
Jan 20251006
Feb 2025202
Mar 2025003
Apr 2025003
May 2025003
Jun 2025003
Total30500221